Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Accelerate Diagnostics Q4 Sales $2.800M Miss $3.020M Estimate

Author: Benzinga Newsdesk | March 21, 2025 08:32am
Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly sales of $2.800 million which missed the analyst consensus estimate of $3.020 million by 7.28 percent. This is a 7.50 percent decrease over sales of $3.027 million the same period last year.

Posted In: AXDX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist